Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:07 AM
Ignite Modification Date:
2025-12-25 @ 12:07 AM
NCT ID:
NCT03254758
Eligibility Criteria:
Inclusion Criteria:
* Men and women ≥ 20 years of age
* Chronic hepatitis C or nonalcoholic steatohepatitis(NASH)
* Child-Pugh grade B liver cirrhosis
* ECOG Performance Status ≤ 2
Exclusion Criteria:
* Liver cirrhosis patients other than hepatitis C or NASH
* Malignant neoplasm (except hepatocellular carcinoma patients without recurrence more than 2 years)
* History of venous thrombosis or pulmonary embolism
* Serum creatinine ≥ 2 mg/dL or T-Bil ≥ 5.0 mg/dL
* Infection with hepatitis B, HIV, ATLV-1 or parvovirus B19
* Patients experienced transplantation or cell therapy
* Pregnancy or positive on pregnancy test
* Complications of significant heart disease, kidney disorder, or respiratory disease
* Drug or alcohol abuse
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT03254758
Study Brief:
Protocol Section:
NCT03254758